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Abstract: Olfactory dysfunction is common among older adults and
affects their safety, nutrition, quality of life, and mortality. More
importantly, the decreased sense of smell is an early symptom of
neurodegenerative diseases such as Parkinson disease (PD) and Alz-
heimer disease. However, the genetic determinants for the sense of
smell have been poorly investigated. We here performed the first
genome-wide meta-analysis on the sense of smell among 6252 US
older adults of European descent from the Atherosclerosis Risk in
Communities (ARIC) study, the Health, Aging, and Body Compositionsley Jr, PhD, Jaya D,
Honglei Chen, MD, PhD
meta-analyzed using fixed-effect models with inverse variance weights.
Although no SNPs reached genome-wide statistical significance, we
identified 13 loci with suggestive evidence for an association with the
sense of smell (Pmeta< 1 105). Of these, 2 SNPs at chromosome
17q21.31 (rs199443 in NSF, P¼ 3.02 106; and rs2732614 in
KIAA1267–LRRC37A, P¼ 6.65 106) exhibited cis effects on the
expression of microtubule-associated protein tau (MAPT, 17q21.31) in
447 frontal-cortex samples obtained postmortem and profiled by RNA-
seq (P< 1 1015). Gene-based and pathway-enrichment analyses
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conclusion, we provide preliminary evidence that the MAPT locus may
play a role in regulating the sense of smell in older adults and therefore
offer a potential genetic link between poor sense of smell and major
neurodegenerative diseases.
(Medicine 94(47):e1892)
Abbreviations: AD = Alzheimer disease, ARIC = Atherosclerosis
Risk in Communities study, B-SIT = Brief Smell Identification
Test, eQTL = expression quantitative trait loci, GWAS = genome-
wide association study, Health ABC = the Health, Aging, and Body
Composition study, MAP = the Rush Memory and Aging Project,
MMSE = Mini-Mental State Examination, NCS = the ARIC Neuro-
Cognitive Study, PD = Parkinson disease, ROS = the Religious
Orders Study.
INTRODUCTION
T he human olfactory system provides us a remarkable abilityto detect and discriminate odorants, and warns us of spoiled
foods or dangerous environments. Olfactory dysfunction may
not only result in poorer nutritional status and adverse effects on
safety and quality of life, but is associated with higher
mortality.1,2
The sense of smell decreases with age. Poor sense of smell
affects over 20% of US older adults.3 Previous research
suggests that the loss of sense of smell is among the earliest
symptoms of neurodegenerative diseases such as Parkinson
disease (PD)4,5 and Alzheimer disease (AD).6 For PD, this
observation is consistent with the Braak hypothesis that Lewy
body deposition first affects the olfactory bulb and lower brain
stem before spreading into substantia nigra and cortex.7 More-
over, as the nasal cavity directly interacts with the environment,
a dual-hit hypothesis was proposed that environmental neuro-
toxicants may initiate PD development in the olfactory struc-
tures decades before PD clinical diagnosis.8 Therefore, research
on the sense of smell in older adults may lead to a better
understanding of the natural history and etiology of PD and
potentially for other neurodegenerative diseases.
However, the genetic basis for the loss of the sense of smell
is largely unknown. Limited studies have suggested that genetic
variations at human olfactory receptors or the ApoE e4 allele
may contribute to variable olfactory sensitivity and percep-
tion.9,10 Two earlier studies also suggest potential links to
regions on chromosome 4q.11,12
Here, we report the first ever genome-wide meta-analysis
on the sense of smell among 6252 US older adults of European
descent from 3 cohorts: the Atherosclerosis Risk in Commu-
nities (ARIC) study, the Health, Aging, and Body Composition
(Health ABC) study, and the Religious Orders Study and the
Rush Memory and Aging Project (ROS/MAP). We further
examined suggestive loci with gene-based analyses, pathway-
enrichment analyses, as well as expression quantitative trait loci
(eQTL) analysis using 447 postmortem prefrontal-cortex tis-
sues. Overall, our results suggest that microtubule-associated
protein tau (MAPT), a major susceptibility gene for PD13,14 and
possibly for AD,15 may also play a role in regulating the sense of
smell in older adults.
METHODS
Dong et alParticipating Studies
Details of participating cohorts were published else-
where.16–19 Briefly, the ARIC study is an ongoing longitudinal
2 | www.md-journal.comstudy that was established in 1987 to 1989 to investigate risk
factors for cardiovascular diseases.16 The sense of smell was
measured as part of the ARIC Neuro-Cognitive Study (NCS) in
2011 to 2013. Of the 6523 participants of ARIC NCS, 4066
were eligible after excluding non-Whites (n¼ 1563), and
participants without valid data on the smell identification test
(n¼ 279) or genome-wide association study (GWAS) genotyp-
ing (n¼ 615). The Health ABC is a prospective study estab-
lished in 1997 to 1998 to investigate risk factors for disability
and functional decline among older adults.17 The sense of smell
was tested among 2537 participants in 1999 to 2000. After
excluding self-reported non-Whites (n¼ 976), participants
without valid data on the smell identification test (n¼ 106)
or GWAS (n¼ 111), 1344 were eligible for analysis. The ROS
and MAP studies are longitudinal cohorts established in mid-
1990s to investigate aging and AD incidence and progression
among adults 65 years or older.18,19 The sense of smell was
measured as part of its clinical evaluation. Our analysis included
1065 Whites after excluding participants without data on gen-
otyping (n¼ 661) or the sense of smell (n¼ 644).
The Smell Identification Tests
All 3 cohorts used validated smell identification tests to
examine the sense of smell: the 12-item Sniffin’ Sticks screen-
ing test (Burghart, Wedel, Germany)20 in ARIC and the 12-item
Brief Smell Identification Test (B-SIT, Sensonics, Haddon
Heights, NJ)21 in the Health ABC and ROS/MAP. Both tests
assess participant’s sense of smell to correctly identify 12 daily
odorants, although the exact odorants were somewhat different.
Briefly, participants were instructed to smell each odorant and
choose the correct odorant from 4 possible answers in a
multiple-choice format. One point was given for each correct
answer with a total score from 0 to 12. Both tests have been
validated and widely used in clinical and epidemiological
studies.20,21
All cohorts assessed global cognitive function during
the same study visit in which the sense of smell was evaluated.
The ARIC and ROS/MAP studies used the Mini-Mental State
Examination (MMSE) that has a maximal score of 30, whereas
the Health ABC study used the Modified Mini-Mental
Status Examination (MMMSE) with a maximal score of 100.
Each cohort also determined ApoE genotypes by genotyping 2
ApoE variants at codons 130 and 176 (formerly 112 and
158) separately.
Genotyping, Imputation, and Statistical Analysis
GWAS genotyping was performed using the Affymetrix
Genome-wide Human SNP array 6.0 in ARIC and ROS/MAP,
and Illumina Human1M-Duo BeadChip in Health ABC. Impu-
tation was performed in each cohort using MACH based on
HapMap Phase II CEU build 36 reference panel. Prespecified
criteria were used for quality control of each cohort.
Each cohort performed its own GWAS analysis following a
standardized procedure with ProbABEL22 or PLINK,23 using a
linear regression model with analysis of allele dosages. The
outcome was the natural log of the sense of smell score plus 1 to
account for the few participants who had a score of 0. Potential
confounders were adjusted for in 2 separate models: first for
age, gender, study sites, cognitive function, and the first 2
principal components (PCAs) in Model 1, and then additionally
Medicine  Volume 94, Number 47, November 2015for ApoE e4 allele in Model 2. We further adjusted for ApoE e4
because it is the most important genetic risk factor for AD and
predicts poor sense of smell in all participating cohorts.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
We performed meta-analysis using a fixed-effect model
with inverse variance weights in METAL,24 after filtering out
SNPs with MAF< 1% 25–27 or low imputation quality
(r2< 0.3). We applied genomic control for each dataset before
meta-analysis (e-Methods). We considered P value< 5 108
as genome-wide significant and P value between 1 105 and
5 108 as suggestive evidence for an association.
We used VEGAS28 (Versatile Gene-based Association
Study) for gene-based analysis and calculated individual
gene-wise P values for each gene in relation to the sense of
smell, and used binomial test to identity enriched ingenuity
canonical pathways (http://www.ingenuity.com; IPA, Ingenu-
ity1 Systems) based on the results of meta-analysis in Model 2,
the enrichment test P values were derived from 10,000 rounds of
permutation tests (e-Methods).
To explore the functional relevance of top SNPs from the
GWAS analysis, we applied the publicly available data from the
RegulomeDB (http://regulomedb.org/)29 (e-Methods). We then
generated RNA expression data using frozen postmortem dor-
solateral prefrontal cortex (DLPFC) brain tissue from 447 ROS/
MAP participants to define the biological consequence of the
risk variants of identified SNPs (e-Methods).
Ethical Aspects
Individual study protocols were approved by relevant
institutional review boards and all study participants provided
written consent.
RESULTS
Table 1 presents characteristics of study participants. As
expected, the sense of smell decreased with age and was lower
in men than women. Further, higher cognitive score was
associated with better sense of smell, whereas the ApoE e4
allele was related to poorer sense of smell. These population
characteristics were similarly associated with the sense of smell
Medicine  Volume 94, Number 47, November 2015across cohorts (Table S1, http://links.lww.com/MD/A526).
Although these studies used different screening tests of smell
identification, the distributions of the sense of smell scores were
TABLE 1. Population Characteristics of Participating Cohorts
ARIC
N 3843
Age at assessment (y), meanSD 75.87 5.19
Men, % 44.05
Smell identification score, meanSD 9.50 2.31
Overall cognitive function









For ApoE, numbers do not add up to total due to missing values. ARIC¼ th
Aging, and Body Composition study, APOE¼ Apolipoprotein E, MMSE
MMMSE¼Modified Mini Mental Status Examination, range of possible s
Memory and Aging Project, SD¼ standard deviation.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.comparable across cohorts (Figure S1, http://links.lww.com/
MD/A526).
The Q–Q plots for Model 1 showed relatively low geno-
mic inflation factors (overall l¼ 0.996), suggesting minimal
population stratification (Figure S2, http://links.lww.com/MD/
A526). Although no SNP reached genome-wide significance,
35 SNPs had a suggestive association with the sense of smell
(Pmeta< 1 105, Figure 1A). We examined LD among these
SNPs and identified 19 SNPs that either had the lowest P value
in each LD block (r2  0.8) or were potentially functional as
annotated in the RegulombDB (Tables S2 and S3, http://
links.lww.com/MD/A526). Among these, 3 SNPs were pre-
dicted as eQTLs in frontal-cortex and cerebellum tissues in the
RegulomeDB: rs199443 (NSF, Pmeta¼ 4.01 106),
rs2075650 (TOMM40, Pmeta¼ 4.24 106), and rs2732614
(KIAA1267–LRRC37A, Pmeta¼ 8.34 106). The rs199443
and rs2732614 were cis-eQTLs for MAPT in both frontal-cortex
and cerebellum tissues,30 while rs2075650 was cis-eQTL for
TOMM40 in lymphoblastoid cells.31
In the meta-analysis of Model 2 that further adjusted for
ApoE e4, the Q–Q plot also showed a relatively low genomic
inflation factor with an overall l of 0.996 (Figure S2, http://
links.lww.com/MD/A526). As shown in Table 2 and Figure 1B,
13 SNPs had suggestive associations with the sense of smell
(Pmeta< 1 105, Figure S3, http://links.lww.com/MD/A526);
another 47 SNPs were in LD (r2  0.8) with these 13 SNPs
(Table S4, http://links.lww.com/MD/A526). Ten of these 13
SNPs overlapped with those from Model 1, including the
2 annotated eQTLs at chromosome 17: rs199443
(Pmeta¼ 3.02 106) and rs2732614 (Pmeta¼ 6.65 106).
In contrast, the signal for rs2075650 at TOMM40 was drastically
diminished (Pmeta¼ 0.09) after adjustment for ApoE e4. For
these 13 SNPs, we also repeated the meta-analyses using
random-effect model and observed similar results. For example,
the Pmeta was 3.73 106 for rs199443 and 8.25 106 for
rs2732614 under the random-effect model.
GWAS of the Sense of SmellWe conducted gene-based analysis using VEGAS28 to
identify genes that harbor multiple association signals based
on Pmeta values from the model that adjusted for ApoE. The
Health ABC ROS/MAP
1344 1065
75.70 2.81 81.52 6.85
52.98 27.51
10.52 2.12 8.62 2.51
NA 27.54 3.05
92.89 5.96 NA
9 (0.68) 6 (0.62)
167 (12.63) 146 (15.19)
22 (1.66) 16 (1.66)
) 827 (62.56) 597 (62.16)
280 (21.18) 180 (18.73)
17 (1.29) 16 (1.66)
e Atherosclerosis Risk in Communities study, Health ABC¼ the Health,
¼Mini-Mental State Examination, range of possible score 0 to 30,
core 0 to 100, ROS/MAP¼ the Religious Orders Study and the Rush
www.md-journal.com | 3




Dong et al Medicine  Volume 94, Number 47, November 2015SNPs were mapped to 17,693 genes. No genes were statistically
significant after Bonferroni correction (P< 2.8 106¼ 0.05/
17,693). Genes with P< 1.0 103 were listed in Table S5,
http://links.lww.com/MD/A526. Interestingly, MAPT (Pgene¼
9.4 105) was among the top genes identified in this analysis
along with nearby LRRC37A (Pgene¼ 2.9 105) and NSF
(Pgene¼ 1.4 105), all located on chromosome 17. LRRC37A
and NSF each harbor 1 of the 2 annotated eQTLs (rs2732614 and
rs199443, respectively) whereas the expression of MAPT is
regulated by both SNPs in brain tissues.30
We further conducted 2 pathway enrichment analyses (top
10 identified pathways listed in Table S6, http://links.lww.com/
MD/A526). The first analysis was based on results from Model
2 and we observed 21 significantly enriched canonical pathways
with the permutation P< 0.05. These include the CDK5 and
p38 MAPK signaling pathways both of which are implicated in
neurodegeneration and MAPT is a member of both pathways.
The second analysis were based on the 164 genes with
Pgene< 0.01 identified by VEGAS. This analysis identified
113 enriched canonical pathways with the permutation
P< 0.05. The CDK5 signaling pathway was again identified
as 1 of the top ranked pathways.
We further examined MAPT expression using RNA-seq
data of 447 postmortem frontal-cortex tissues from the ROS/
MAP study in order to define the biological consequence of the
risk variants of rs2732614 and rs199443. We found strong
correlations between genotypes of the risk allele (C allele for
both rs2732614 and rs199443) and higher expression level of
MAPT (P< 1015, Figure 2); however, we observed no signifi-
cant correlation between these 2 SNPs and the expression levels
of NSF or LRRC37A (rs2732614: P¼ 0.62 for NSF and 0.54 for
FIGURE 1. Manhattan plots of the genome-wide meta-analysis on t
threshold (5108) and the blue line indicates the suggestive thre
cognitive function, and the first 2 principal components; (B) ModLRRC37A; rs199443: P¼ 0.79 for NSF and 0.11 for LRRC37A).
As MAPT is 1 of the most important susceptibility genes for
PD, we further performed a sensitivity analysis for the 13 SNPs
4 | www.md-journal.comidentified in Model 2 by removing potential PD cases based on
sense of smell. The red line indicates the genome-wide significance
ld (1105). (A) Model 1 adjusted for age, gender, study center,
further adjusted for ApoE e4 allele.ARIC, 14 in Health ABC, and 12 in ROS/MAP) and obtained
similar results (Table S7, http://links.lww.com/MD/A526).
DISCUSSION
To the best of our knowledge, this is the first genome-wide
meta-analysis on the sense of smell among older adults. The
study population includes 3 well-characterized aging cohorts
with objective measurements for smell identification. Although
no SNP reached genome-wide significance, the preponderance
of the evidence suggests MAPT as a potential susceptibility
locus for poor sense of smell. This is particular interesting
because MAPT is 1 of the most important susceptibility genes
for late-onset sporadic PD13,14 and possibly for AD.15
Smell impairment is common among older adults, particu-
larly in patients with neurodegenerative diseases. More impor-
tantly, recent data suggest that decreased sense of smell may
precede the clinical onset of both PD4,5 and AD.6 For example,
in the Honolulu Asia Aging Study, individuals in the lowest
quartile of the sense of smell score were 5 times more likely to
develop PD in the next 4 years than those in the highest
quartile5; further poor sense of smell was associated with higher
prevalence of incidental Lewy bodies in postmortem brains, a
condition that may represent prodromal PD.32 Similar obser-
vations have also been made for both mild cognitive impairment
and AD.6,33 Therefore, the declining sense of smell in older
adults may indicate underlying neurodegenerative processes.
Characterizing the genetic and environmental determinants for
the sense of smell in the context of aging may provide targets for
intervention with enormous potential translational impact.
The human MAPT locus has long been associated with the
risk for PD.13,14 A recent meta-analysis of GWAS data further
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Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.implicated MAPT as a susceptibility locus for late onset spora-
dic AD.15 The human MAPT encodes the microtubule-associ-
ated protein tau. It is notable that tau-related pathology was
found in the bulbar component of the anterior olfactory nucleus
only in patients of neurodegenerative disorders with marked
loss of the sense of smell, such as AD, PD, and Lewy body
dementia.34,35 Experimental studies further suggest that over-
expression of tau may contribute to olfactory dysfunction in
vivo.36,37 These findings indicate that overexpression or abnor-
mal aggregation of tau may represent a common mechanism
between olfactory dysfunction and several neurodegenerative
diseases.
The genomic architecture in the region spanning MAPT is
highly complex. It covers 1.8 Mb block of LD encompassing
not only MAPT but also several other genes that have been
linked to neurodegenerative diseases, such as STH (Saitohin)
and NSF (N-ethylmaleimide sensitive factor). We, however, in
the RNA-seq data of 447 postmortem frontal-cortex tissues,
found that rs2732614 and rs199443 had statistically significant
cis effects on the expression of MAPT (P< 1015), but not on
NSF or LRRC37A. Additional gene-based and pathway-enrich-
ment analyses also showed the potential of MAPT as a candidate
susceptibility gene for poor sense of smell. Although our study
provides fairly consistent evidence that MAPT may be a candi-
date susceptibility locus for the sense of smell in older adults of
European descent, fine-scale mapping of this LD block with
next generation sequencing will be necessary to identify poten-
tial causal locus.
ApoE e4 is the most important genetic risk factor for late-
onset sporadic AD38 and has been linked to olfactory dysfunc-
tion in several studies.9 The present study confirms that the
ApoE e4 allele is a risk factor for poor smell identification even
after accounting for cognitive function. In our initial analysis,
we also identified an intronic SNP in TOMM40 (rs2075650) in
association with the sense of smell; but this signal was extin-
guished after adjustment for the ApoE e4 allele. Although the
mechanisms are yet unknown, preliminary studies showed that
ApoE was expressed at high levels in various types of cells in
the olfactory epithelium and its underlying lamina propria, and
that ApoE might play a critical role in olfactory nerve regen-
eration in mice.39,40 Furthermore, experimental studies suggest
that in contrast to the ApoE e2 and e3 alleles, the ApoE e4 fails to
promote neurite outgrowth in olfactory epithelium cultures,
which may lead to olfactory dysfunction in AD.41
The main limitation of the current study was the lack of
independent confirmation of GWAS signals. GWAS analysis
often requires very large sample size to obtain adequate power
to detect modest effects of underlying variants in complex
diseases. However, few large population-based studies of older
adults have both the sense of smell and GWAS data. We were
able to identify data from 3 well-established cohorts with
similar population characteristics and data collection. We chose
to combine our samples for SNP discovery rather than set up the
conventional 2-stage design to maximize power to detect
signals. We did, however, follow up suggestive signals with
functional and expression analyses. Finally, the determinants
for the sense of smell are likely complex42,43 and our study was
conducted among old White adults, therefore the results should
be interpreted in this context. Further studies are needed to
confirm our findings and to examine whether they could be
generalized to other populations.
GWAS of the Sense of SmellIn conclusion, we report the results of the first compre-
hensive GWAS analysis to understand the genetic basis for the
sense of smell in older adults of European ancestry. We provide
www.md-journal.com | 5




Dong et al Medicine  Volume 94, Number 47, November 2015novel evidence that the MAPT locus may regulate the sense of
smell in older adults. This finding warrants independent con-
firmation and further mechanistic investigations into how
MAPT region contributes to the loss of the sense of smell
and the development of related neurodegenerative diseases.
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